Psychopharmacology and Psychiatry Updates
Un pódcast de Psychopharmacology Institute
Categorías:
213 Episodo
-
Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19
Publicado: 29/9/2021 -
How to Assess Psychotropic Drug Adherence
Publicado: 24/9/2021 -
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)
Publicado: 19/9/2021 -
Delirium, Catatonia, and COVID-19
Publicado: 14/9/2021 -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Publicado: 9/9/2021 -
Dopamine and Depression: Clinical Considerations
Publicado: 4/9/2021 -
Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium
Publicado: 30/8/2021 -
New Somatic Treatments for Child and Adolescent Depression
Publicado: 25/8/2021 -
Management of Delirium: Nonpharmacologic Strategies
Publicado: 20/8/2021 -
Emerging Complementary and Integrative Therapies for Geriatric Mental Health
Publicado: 15/8/2021 -
Delirium: Assessment, Consequences, and Sequelae
Publicado: 10/8/2021 -
In Search of a Dose-Response Relationship in SSRIs
Publicado: 5/8/2021 -
Valproate/Divalproex: Metabolism, Kinetics, and Warnings
Publicado: 31/7/2021
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.